deltatrials
Completed PHASE4 NCT00403650

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension

Sponsor: University of Cincinnati

Conditions Pulmonary Arterial Hypertension Sarcoidosis
Interventions Iloprost
Updated 5 times since 2017 Last updated: Apr 10, 2013 Started: Nov 30, 2006 Primary completion: Jul 31, 2008 Completion: Sep 30, 2008

This PHASE4 trial investigates Pulmonary Arterial Hypertension and Sarcoidosis and is currently completed. University of Cincinnati leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Cincinnati
Data source: University of Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Cincinnati, United States